Department of Physiology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan ; Department of Pediatrics, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.
Department of Physiology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan ; Department of Neurology, School of Medicine, Aichi Medical University, 1-1 Yazako Karimata, Nagakute, Aichi 480-1195, Japan.
Stem Cell Reports. 2014 Apr 24;2(5):648-61. doi: 10.1016/j.stemcr.2014.03.007. eCollection 2014 May 6.
Pelizaeus-Merzbacher disease (PMD) is a form of X-linked leukodystrophy caused by mutations in the proteolipid protein 1 (PLP1) gene. Although PLP1 proteins with missense mutations have been shown to accumulate in the rough endoplasmic reticulum (ER) in disease model animals and cell lines transfected with mutant PLP1 genes, the exact pathogenetic mechanism of PMD has not previously been clarified. In this study, we established induced pluripotent stem cells (iPSCs) from two PMD patients carrying missense mutation and differentiated them into oligodendrocytes in vitro. In the PMD iPSC-derived oligodendrocytes, mislocalization of mutant PLP1 proteins to the ER and an association between increased susceptibility to ER stress and increased numbers of apoptotic oligodendrocytes were observed. Moreover, electron microscopic analysis demonstrated drastically reduced myelin formation accompanied by abnormal ER morphology. Thus, this study demonstrates the involvement of ER stress in pathogenic dysmyelination in the oligodendrocytes of PMD patients with the PLP1 missense mutation.
佩利兹-梅茨巴赫病(PMD)是一种 X 连锁脑白质营养不良,由蛋白脂蛋白 1(PLP1)基因突变引起。虽然带有错义突变的 PLP1 蛋白已被证明在疾病模型动物和转染突变 PLP1 基因的细胞系的粗面内质网(ER)中积累,但 PMD 的确切发病机制尚未阐明。在这项研究中,我们从两名携带错义突变的 PMD 患者中建立了诱导多能干细胞(iPSC),并在体外将其分化为少突胶质细胞。在 PMD iPSC 衍生的少突胶质细胞中,观察到突变型 PLP1 蛋白向 ER 的定位错误,以及 ER 应激易感性增加与凋亡少突胶质细胞数量增加之间的关联。此外,电子显微镜分析表明髓鞘形成明显减少,伴随 ER 形态异常。因此,这项研究表明 ER 应激参与了具有 PLP1 错义突变的 PMD 患者少突胶质细胞的致病性脱髓鞘。